Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07235202 Clinical Landscape Report 2026
16 October 2026
NCT07235202 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Irinotecan Hydrochloride Lioposome in Metastatic Pancreatic Cancer: NCT07238283 Clinical Landscape Report 2026
16 October 2026
NCT07238283 clinical landscape for Metastatic Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TC-G203 in Advanced Malignant Solid Neoplasm: NCT07242417 Clinical Landscape Report 2026
16 October 2026
NCT07242417 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
RO-7812653 in Alzheimer Disease: NCT07234942 Clinical Landscape Report 2026
16 October 2026
NCT07234942 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-4642 in Pancreatic adenocarcinoma: NCT07240766 Clinical Landscape Report 2026
16 October 2026
NCT07240766 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DEG-6498 in Hepatocellular Carcinoma: NCT07244835 Clinical Landscape Report 2026
16 October 2026
NCT07244835 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Hepatocellular Carcinoma: NCT07243691 Clinical Landscape Report 2026
16 October 2026
NCT07243691 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cadonilimab in Hepatocellular Carcinoma: NCT07243951 Clinical Landscape Report 2026
16 October 2026
NCT07243951 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Edaravone in Alzheimer Disease: NCT07252440 Clinical Landscape Report 2026
16 October 2026
NCT07252440 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic adenocarcinoma: NCT07253662 Clinical Landscape Report 2026
16 October 2026
NCT07253662 clinical landscape for Pancreatic adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Etrasimod Arginine in Colitis, Ulcerative: NCT07243639 Clinical Landscape Report 2026
16 October 2026
NCT07243639 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Daraxonrasib in Pancreatic Ductal Adenocarcinoma: NCT07252232 Clinical Landscape Report 2026
16 October 2026
NCT07252232 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…